Evaluating the Obstetric Comorbidity Index for predicting severe maternal morbidity in postpartum hemorrhage after cesarean delivery
Obstetric Comorbidity Index for Prediction of Perioperative Severe Maternal Morbidity in Patients Undergoing Cesarean Delivery With Postpartum Hemorrhage
This study is testing if a special scoring system can help doctors predict serious health problems after cesarean delivery due to heavy bleeding in new mothers.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 576 (estimated) |
| Sex | Female |
| Sponsor | Mahidol University Academic / other |
| Locations | 1 site (Bangkok) |
| Trial ID | NCT06431204 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the effectiveness of the Obstetric Comorbidity Index (OBCMI) in predicting severe maternal morbidity associated with postpartum hemorrhage in patients who have undergone cesarean delivery. The OBCMI, developed in 2013, has shown superior predictive capabilities compared to general comorbidity measures in obstetric populations. The study will analyze the correlation between the OBCMI and maternal morbidity, focusing on the prevalence of comorbidities during the perioperative period in a Thai context, which has not been previously explored. By enhancing risk assessment tailored to obstetric patients, the study seeks to improve maternal outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are women who have undergone cesarean delivery and are diagnosed with postpartum hemorrhage.
Not a fit: Patients who have had a cesarean delivery at less than 24 weeks of gestation or those with insufficient medical records will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better risk assessment and management strategies for women experiencing postpartum hemorrhage, ultimately improving maternal health outcomes.
How similar studies have performed: Previous studies have validated the Obstetric Comorbidity Index in various countries, demonstrating its predictive accuracy for maternal morbidities, although this specific application in Thailand is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: The patients underwent cesarean delivery with the diagnosis of postpartum hemorrhage (ICD-10 coding O72.1) Exclusion Criteria: * Cesarean delivery at less than 24 weeks of gestation * A patient chart that does not contain primary outcome data eg. absence of anesthetic record * Blood loss less than 1,000 ml in the first 24 hours postpartum
Where this trial is running
Bangkok
- Faculty of Medicine Siriraj Hospital — Bangkok, Thailand (Recruiting)
Study contacts
- Principal investigator: Patchareya Nivatpumin, M.D. — Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok THAILAND
- Study coordinator: Patchareya Nivatpumin, M.D.
- Email: patchareya.niv@gmail.com
- Phone: +66896662187
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.